FDA Cosmetics Office Shifts Focus As Bioterrorism, BSE Take Priority
This article was originally published in The Rose Sheet
Executive Summary
FDA initiatives to counter potential bioterrorism through agency-regulated products - including cosmetics - have prompted a priority shift for the agency's Office of Cosmetics & Colors, Division of Science and Applied Technology Director Adele Dennis, PhD, said
You may also be interested in...
CTFA Monitoring Bioterrorism Legislation To Preserve Self-Regulation
Bioterrorism legislation under review by Congress has the potential to spark additional regulation within the cosmetics industry, Cosmetic, Toiletry and Fragrance Association Legislative Relations VP Michael Thompson said during the trade group's annual meeting in Boca Raton, Fla. Feb. 28-March 3
CTFA Monitoring Bioterrorism Legislation To Preserve Self-Regulation
Bioterrorism legislation under review by Congress has the potential to spark additional regulation within the cosmetics industry, Cosmetic, Toiletry and Fragrance Association Legislative Relations VP Michael Thompson said during the trade group's annual meeting in Boca Raton, Fla. Feb. 28-March 3
FDA Cosmetics Office Aims To Achieve Three “A” List Priorities In 2002
FDA's Office of Cosmetics & Colors will tackle three "A" list items and 10 "B" list goals in fiscal 2002 under the Center for Food Safety & Applied Nutrition's program priorities report issued Jan. 28